The volume of evidence behind a therapy has become inversely correlated with public trust in it,” writes Vikas Patel.
A Supreme Court ruling this week on gender and sexuality “conversion therapy” could narrow the authority of state medical ...
Lenacapavir could put the end of the HIV epidemic in reach — if the people who need it can access it. Here’s one way to make ...
The taxes are part of the president's push to rein in the pharmaceutical industry and bring manufacturing to the U.S.
The final regulation, released Thursday by President Trump’s Centers for Medicare and Medicaid Services, is significantly ...
The CDC has “temporarily paused” diagnostic testing for rabies and pox viruses, according to a recent update to the agency ...
The Trump administration is negotiating new drug-pricing deals, now with smaller companies, according to three people with ...
On top of being a day for brands to post “pranks” on social media, April 1 was also the deadline to apply for the CMMI ACCESS ...
Cuts to health care spending might play a role in a complicated Congressional maneuver to fund immigration enforcement.
The FDA yesterday approved Eli Lilly’s weight loss pill, orforglipron. The agency is also facing renewed scrutiny over ...
A recent survey from The Physicians Foundation found that over half of doctors cite mis- and disinformation as hindering ...
An analysis of AI-powered devices that received FDA's "breakthrough" label shows a preference for big-picture, multi-problem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results